Oscillatory Activity in the Nucleus Basalis of Meynert
Objective: Characterize oscillatory activity in and around the nucleus basalis of Meynert (NBM). Background: The NBM is the major source of cholinergic innervation to the…New method to evaluate new motor skill learning
Objective: To present a novel approach to assessing improvements in new motor skill learning. Background: Several methods have been employed over the years to try…Development of utility to evaluate a symptomatic diary of motor fluctuations of Parkinson’s disease (PD) using a smartphone application.
Objective: To investigate the utility of a symptomatic diary of motor fluctuations of Parkinson's disease (PD) using a smartphone application. Background: In the conference last…The combination of clinical scales and walking measures to predict falls in Parkinson’s disease: Does the length of the prospective follow-up period matter?
Objective: This study aimed: (i) to identify the best combination of clinical scales and walking measures to predict falls in people with Parkinson’s disease (PD)…Management of fragility fractures in Parkinson’s Disease (PD)
Objective: To assess the management of osteoporotic fragility fractures in patients with PD attending a Movement disorders clinic. Background: Patients with PD have a high…Self Perception of Dysphagia in Parkinson Disease
Objective: To determine when individuals with Parkinson disease (PD) perceive impairment of swallowing as it relates to time since diagnosis. Background: Dysphagia, and particularly silent…CSF, plasma and saliva alpha-Synuclein in moderately advanced Parkinson’s disease cohort: the BioFIND study
Objective: To test if alpha-synuclein (α-syn) levels in CSF, plasma and saliva predict PD status in the BioFind cohort, and to test whether α-syn levels…Neuroprotective propensity of PTUPB, a dual inhibitor of sEH and COX-2 against rotenone induced neurotoxicity in cell line and Drosophila model of Parkinson disease
Objective: To evaluate the potential anti-parkinson activity of PTUPB (4-(5-phenyl-3-{3-[3-(4-trifluoromethyl-phenyl)-ureido]-propyl}-pyrazol-1-yl)-benzenesulfonamide) a dual inhibitor of soluble Epoxide hydrolase (sEH) and cyclooxygenase-2 (COX-2) against rotenone induced mitochondrial dysfunction,…3D image as a complimentary assist in patients with Parkinson’s disease
Objective: To assist patients with PD to overcome the fear of stair ascent and descent with help of 3D effect staircase Background: Since walking on…Falls characteristics of male and female patients with Parkinson’s disease (PD)
Objective: To compare Falls risk characteristics in male and female PD patients attending a multidisciplinary Movement disorders clinic. Background: Parkinson’s disease is commoner in males.…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.